Here's Why You Should Invest in Aldeyra (ALDX) Stock Now
ALDXAldeyra Therapeutics(ALDX) Zacks Investment Research·2024-03-06 23:41

Burlington, MA-based Aldeyra Therapeutics (ALDX) is a leader in the development of RASP (reactive aldehyde species) modulators for the treatment of immune-mediated diseases. Lately, it has seen success in its studies on its investigational RASP modulator, ADX-629, which has demonstrated potential activity in clinical studies of patients with psoriasis, asthma, COVID, ethanol toxicity, chronic cough and atopic dermatitis.Aldeyra Therapeutics is conducting a phase II study on ADX-629 in Sjögren-Larsson Syndro ...